Search
Medicus Pharma Ltd
MDCXAdd to Watchlist
0.401USD
-0.045-10.11%
Market hours （ET）Quotes delayed by 15 min
16.05MMarket Cap
LossP/E TTM
More Details of Medicus Pharma Ltd Company
Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. SkinJect Inc., a wholly owned subsidiary of the Company, is a development stage, life sciences company focused on commercializing novel, non-invasive treatment for basal cell skin cancer using a patented dissolvable microneedle patch to deliver a chemotherapeutic agent to eradicate tumors cells. It is conducting a randomized, controlled, double-blind, multicenter clinical study (SKNJCT-003) in the United States and Europe. It has also commenced a randomized, controlled, double-blind, multicenter clinical study (SKNJCT-004) in the UAE. Its subsidiary, Antev Limited, is a late clinical stage biotech company, developing Teverelix, a GnRH antagonist, as a first in market product for cardiovascular high-risk advanced prostate cancer patients and patients with first acute urinary retention relapse episodes due to enlarged prostate.
Medicus Pharma Ltd Info
Ticker SymbolMDCX
Company nameMedicus Pharma Ltd
IPO dateOct 11, 2023
CEOBokhari (Raza)
Number of employees12
Security typeOrdinary Share
Fiscal year-endOct 11
Address300 Conshohocken State Rd.
CityCONSHOHOCKEN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code19428
Phone16105407515
Websitehttps://medicuspharma.com/
Ticker SymbolMDCX
IPO dateOct 11, 2023
CEOBokhari (Raza)
Company Executives of Medicus Pharma Ltd
Name
Name/Position
Position
Shareholding
Change
Dr. Raza Bokhari, M.D.
Dr. Raza Bokhari, M.D.
Executive Chairman, of the Board, Chief Executive Officer
Executive Chairman, of the Board, Chief Executive Officer
793.17K
--
Mr. Patrick J. Mahaffy
Mr. Patrick J. Mahaffy
Director
Director
60.44K
+41.37%
Ms. Carolyn F. Bonner
Ms. Carolyn F. Bonner
President, Chief Financial Officer
President, Chief Financial Officer
18.91K
--
Mr. William L. (Bill) Ashton
Mr. William L. (Bill) Ashton
Independent Director
Independent Director
1.25K
--
Mr. Andrew A. Smith
Mr. Andrew A. Smith
Chief Operating Officer
Chief Operating Officer
164.00
--
Dr. Sara R. May, Ph.D.
Dr. Sara R. May, Ph.D.
Director
Director
--
--
Dr. Faisal Mehmud, M.D.
Dr. Faisal Mehmud, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Edward J. Brennan, Jr., M.D.
Dr. Edward J. Brennan, Jr., M.D.
Chief Scientific Officer, Head of Research and Development Program
Chief Scientific Officer, Head of Research and Development Program
--
--
Dr. Larry R. Kaiser
Dr. Larry R. Kaiser
Independent Director
Independent Director
--
--
Mr. Robert J. Ciaruffoli, CPA
Mr. Robert J. Ciaruffoli, CPA
Lead Independent Director
Lead Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Raza Bokhari, M.D.
Dr. Raza Bokhari, M.D.
Executive Chairman, of the Board, Chief Executive Officer
Executive Chairman, of the Board, Chief Executive Officer
793.17K
--
Mr. Patrick J. Mahaffy
Mr. Patrick J. Mahaffy
Director
Director
60.44K
+41.37%
Ms. Carolyn F. Bonner
Ms. Carolyn F. Bonner
President, Chief Financial Officer
President, Chief Financial Officer
18.91K
--
Mr. William L. (Bill) Ashton
Mr. William L. (Bill) Ashton
Independent Director
Independent Director
1.25K
--
Mr. Andrew A. Smith
Mr. Andrew A. Smith
Chief Operating Officer
Chief Operating Officer
164.00
--
Dr. Sara R. May, Ph.D.
Dr. Sara R. May, Ph.D.
Director
Director
--
--
FAQs
Who are the top five shareholders of Medicus Pharma Ltd?
The top five shareholders of Medicus Pharma Ltd are: Dr. Raza Bokhari, M.D.
How many institutions hold shares of Medicus Pharma Ltd (MDCX)?
As of 2026Q1, 38 institutions hold shares of Medicus Pharma Ltd, with a combined market value of approximately 4.15M, accounting for 7.52% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 1672664.00.